Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Consolidated Net Income (2016 - 2025)

Creative Medical Technology Holdings has reported Consolidated Net Income over the past 16 years, most recently at -$2.2 million for Q4 2025.

  • Quarterly Consolidated Net Income rose 25.09% to -$2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.3 million through Dec 2025, up 4.21% year-over-year, with the annual reading at -$6.3 million for FY2025, 4.21% up from the prior year.
  • Consolidated Net Income was -$2.2 million for Q4 2025 at Creative Medical Technology Holdings, down from -$1.2 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $27.8 million in Q1 2021 and troughed at -$6.2 million in Q4 2022.
  • The 5-year median for Consolidated Net Income is -$1.5 million (2023), against an average of -$458622.6.
  • The largest YoY upside for Consolidated Net Income was 643.79% in 2021 against a maximum downside of 566.91% in 2021.
  • A 5-year view of Consolidated Net Income shows it stood at -$3.9 million in 2021, then tumbled by 60.39% to -$6.2 million in 2022, then skyrocketed by 72.99% to -$1.7 million in 2023, then plummeted by 77.34% to -$3.0 million in 2024, then increased by 25.09% to -$2.2 million in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Consolidated Net Income are -$2.2 million (Q4 2025), -$1.2 million (Q3 2025), and -$1.2 million (Q2 2025).